Back to search

Article

Role of Intratumoral Heterogeneity in Metastatic Progression and Drug Resistance

2025-04-27

Abstract excerpt

Metastatic cancer is the final frontier in disease progression with few avenues of treatment open to patients. The failure of therapeutic options at the end-stage disease is confounded by the presence of diverse clones in the metastatic tumor which contributes to intratumoral heterogeneity (ITH) resulting in intrinsic and acquired drug resistance. We aim to elucidate the contribution of ITH to the development of m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3ce824ea-b929-5b95-b5a6-6fdeaa85d22f
DOI
10.20944/preprints202504.1952.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Role of Intratumoral Heterogeneity in Metastatic Progression and Drug ResistanceDOI 10.20944/preprints202504.1952.v1
Select a neighboring publication to make it the new centre.